Substitution with alternative Anti-TNFα therapy (SAVANT) - Outcomes of a Crohn's disease cohort undergoing substitution therapy with certolizumab

Moheb Boktor, Andrew Motlis, Avinash Aravantagi, Ankur Sheth, Paul Jordan, James Morris, Kenneth Manas, Nazneen Hussain, Urska Cvek, Marjan Trutschl, Felix Becker, J. Steven Alexander

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Fingerprint Dive into the research topics of 'Substitution with alternative Anti-TNFα therapy (SAVANT) - Outcomes of a Crohn's disease cohort undergoing substitution therapy with certolizumab'. Together they form a unique fingerprint.

Medicine & Life Sciences